251 related articles for article (PubMed ID: 29894834)
1. Fatty acid and quaternary ammonium modified chitosan nanoparticles for insulin delivery.
Li H; Zhang Z; Bao X; Xu G; Yao P
Colloids Surf B Biointerfaces; 2018 Oct; 170():136-143. PubMed ID: 29894834
[TBL] [Abstract][Full Text] [Related]
2. Liver-targeted delivery of insulin-loaded nanoparticles via enterohepatic circulation of bile acids.
Zhang Z; Li H; Xu G; Yao P
Drug Deliv; 2018 Nov; 25(1):1224-1233. PubMed ID: 29791242
[TBL] [Abstract][Full Text] [Related]
3. Effective Enhancement of Hypoglycemic Effect of Insulin by Liver-Targeted Nanoparticles Containing Cholic Acid-Modified Chitosan Derivative.
Zhang Z; Cai H; Liu Z; Yao P
Mol Pharm; 2016 Jul; 13(7):2433-42. PubMed ID: 27266268
[TBL] [Abstract][Full Text] [Related]
4. Chitosan/lecithin liposomal nanovesicles as an oral insulin delivery system.
Al-Remawi M; Elsayed A; Maghrabi I; Hamaidi M; Jaber N
Pharm Dev Technol; 2017 May; 22(3):390-398. PubMed ID: 27470482
[TBL] [Abstract][Full Text] [Related]
5. Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin.
Zhang Y; Wei W; Lv P; Wang L; Ma G
Eur J Pharm Biopharm; 2011 Jan; 77(1):11-9. PubMed ID: 20933083
[TBL] [Abstract][Full Text] [Related]
6. Self-assembled lecithin/chitosan nanoparticles for oral insulin delivery: preparation and functional evaluation.
Liu L; Zhou C; Xia X; Liu Y
Int J Nanomedicine; 2016; 11():761-9. PubMed ID: 26966360
[TBL] [Abstract][Full Text] [Related]
7. Efficient mucus permeation and tight junction opening by dissociable "mucus-inert" agent coated trimethyl chitosan nanoparticles for oral insulin delivery.
Liu M; Zhang J; Zhu X; Shan W; Li L; Zhong J; Zhang Z; Huang Y
J Control Release; 2016 Jan; 222():67-77. PubMed ID: 26686663
[TBL] [Abstract][Full Text] [Related]
8. Preparation, characterization, and oral delivery of insulin loaded carboxylated chitosan grafted poly(methyl methacrylate) nanoparticles.
Cui F; Qian F; Zhao Z; Yin L; Tang C; Yin C
Biomacromolecules; 2009 May; 10(5):1253-8. PubMed ID: 19292439
[TBL] [Abstract][Full Text] [Related]
9. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J
ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015
[TBL] [Abstract][Full Text] [Related]
10. Alginate/chitosan nanoparticles are effective for oral insulin delivery.
Sarmento B; Ribeiro A; Veiga F; Sampaio P; Neufeld R; Ferreira D
Pharm Res; 2007 Dec; 24(12):2198-206. PubMed ID: 17577641
[TBL] [Abstract][Full Text] [Related]
11. Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin.
Bhumkar DR; Joshi HM; Sastry M; Pokharkar VB
Pharm Res; 2007 Aug; 24(8):1415-26. PubMed ID: 17380266
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticles of quaternized chitosan derivatives as a carrier for colon delivery of insulin: ex vivo and in vivo studies.
Bayat A; Dorkoosh FA; Dehpour AR; Moezi L; Larijani B; Junginger HE; Rafiee-Tehrani M
Int J Pharm; 2008 May; 356(1-2):259-66. PubMed ID: 18289808
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and characterization of a novel peptide-grafted Cs and evaluation of its nanoparticles for the oral delivery of insulin, in vitro, and in vivo study.
Barbari GR; Dorkoosh F; Amini M; Bahari Javan N; Sharifzadeh M; Atyabi F; Balalaie S; Rafiee Tehrani N; Rafiee Tehrani M
Int J Nanomedicine; 2018; 13():5127-5138. PubMed ID: 30233176
[TBL] [Abstract][Full Text] [Related]
14. Preparation of chitosan-based multifunctional nanocarriers overcoming multiple barriers for oral delivery of insulin.
Li L; Jiang G; Yu W; Liu D; Chen H; Liu Y; Tong Z; Kong X; Yao J
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):278-286. PubMed ID: 27770892
[TBL] [Abstract][Full Text] [Related]
15. Polyglutamic Acid Functionalization of Chitosan Nanoparticles Enhances the Therapeutic Efficacy of Insulin Following Oral Administration.
Urimi D; Agrawal AK; Kushwah V; Jain S
AAPS PharmSciTech; 2019 Feb; 20(3):131. PubMed ID: 30815757
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticles with surface features of dendritic oligopeptides as potential oral drug delivery systems.
Bai Y; Zhou R; Wu L; Zheng Y; Liu X; Wu R; Li X; Huang Y
J Mater Chem B; 2020 Apr; 8(13):2636-2649. PubMed ID: 32129375
[TBL] [Abstract][Full Text] [Related]
17. Polyelectrolyte biomaterial interactions provide nanoparticulate carrier for oral insulin delivery.
Reis CP; Ribeiro AJ; Veiga F; Neufeld RJ; Damgé C
Drug Deliv; 2008 Feb; 15(2):127-39. PubMed ID: 18293199
[TBL] [Abstract][Full Text] [Related]
18. Functional nanoparticles exploit the bile acid pathway to overcome multiple barriers of the intestinal epithelium for oral insulin delivery.
Fan W; Xia D; Zhu Q; Li X; He S; Zhu C; Guo S; Hovgaard L; Yang M; Gan Y
Biomaterials; 2018 Jan; 151():13-23. PubMed ID: 29055774
[TBL] [Abstract][Full Text] [Related]
19. In-vitro and in-vivo cytotoxicity and efficacy evaluation of novel glycyl-glycine and alanyl-alanine conjugates of chitosan and trimethyl chitosan nano-particles as carriers for oral insulin delivery.
Jafary Omid N; Bahari Javan N; Dehpour AR; Partoazar A; Rafiee Tehrani M; Dorkoosh F
Int J Pharm; 2018 Jan; 535(1-2):293-307. PubMed ID: 29138048
[TBL] [Abstract][Full Text] [Related]
20. Effect of mucoadhesive polymers on the in vitro performance of insulin-loaded silica nanoparticles: Interactions with mucin and biomembrane models.
Andreani T; Miziara L; Lorenzón EN; de Souza AL; Kiill CP; Fangueiro JF; Garcia ML; Gremião PD; Silva AM; Souto EB
Eur J Pharm Biopharm; 2015 Jun; 93():118-26. PubMed ID: 25843239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
